Investor Relations

Delivering value to our shareholders with utmost transparency and timely information.

At Mega Lifesciences public company limited

Investor Relations is responsible for delivering value to our shareholders by communicating all the necessary information on a regular basis.

Investment Highlights

Market leading own consumer health and pharmaceutical brands in fast growing developing markets.

Financial Performance in 1H24

Overall operating revenue
THB mn
(Flat YoY)
Gross profit
THB mn
representing 47.7% of operating revenue
SG&A expenses
THB mn
representing 28.7% of operating revenue
Adjusted net profit
THB mn
(down by 11.0% YoY)
Reported net profit
THB mn
(Flat YoY)
Explore more

Latest Documents

Read our recent and archived releases, Financial statements, Quarterly results, Presentations, Publications and One Reports.

Financial Statement
Quarter 2/2024
Download
MD&A
Quarter 2/2024
Download
Presentation and Webcast
The Opportunity Day Q2/2024
View Webcast Download
Form 56-1 One Report
Form 56-1 One Report 2023
Download
Resource Center

SET Announcements

30 September 2024
Right of Shareholders to propose Agenda and Nominees to be elected as Company's Directors, and submit questions in advance for the 2025 Annual General Meeting of Shareholders
Read More
13 August 2024
Management Discussion and Analysis Quarter 2 Ending 30 Jun 2024
Read More
13 August 2024
Financial Performance Quarter 2 (F45) (Reviewed)
Read More
Explore more

IR Calendar

12
Nov
2024
3Q24 earnings announcement
Explore more
NEWS SUBSCRIPTION
KEEP YOURSELF UP TO DATE
with all the latest announcements from the company.
Subscribe Now

IR CONTACT

  • Mr. Manoj Gurbuxani (Primary contact)
  • Mr. Francis Rego
  • Ms. Sujintana Boonworapat
  • Ms. Laila Mitnoi (IR Co-ordinator)
  • Mr. Thomas Abraham
  • Mr. Vivek Dhawan
  • investor@megawecare.com
  • +66 2 769 4230